BIIB vs FER Comparison

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

Ferrovial SE is a Spanish industrial company. The company organizes itself into four segments: Toll Roads, Airports, Construction, and Energy and mobility infrastructures. The Toll Roads segment develops and operates toll roads globally. The Airports segment operates four airports in the United Kingdom, Heathrow, Aberdeen, Glasgow, and Southampton. The Construction segment designs and constructs buildings, transport infrastructure, water projects, and completes civil engineering work. The Energy and mobility infrastructures segment includes the operation of infrastructure for transport, natural resources, utilities, telecommunications, and waste collection and treatment. By country, the USA represents the maximum contribution to revenue, followed by Poland operations.